On Wednesday, July 22, the results of a study carried out by the Albert Einstein College of Medicine and Montefiore Health System, on the use of steroid treatments in COVID-19 patients, was released and published in the Journal of Hospital Medicine. It identified the benefits and risks of steroid treatment in COVID-19 patients.   The study built upon a larger, earlier British steroid study, called Recovery, involving 6,000 patients. The British study found that the steroid, dexamethasone, reduced deaths from COVID-19 by about one third in patients who were on ventilators, and by about one fifth among patients who needed oxygen

Read More